NeuroOne Medical Technologies Corporation Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate
NeuroOne Medical Technologies Corporation (NMTC) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate of 111.90% for the 9-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate · last filed 2024-08-14
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2024-03-31 was 111.70%, a 92.25% increase year-over-year.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2023-12-31 was 112.00%, a 109.35% increase year-over-year.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2023-06-30 was 58.10%, a 8.60% increase year-over-year.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2023-03-31 was 58.10%, a 8.60% increase year-over-year.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2023 was 57.40%, a 7.29% increase from fiscal 2022.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2022 was 53.50%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 12 month |
|---|---|---|---|---|
| 2024-06-30 | 111.90% 10-Q · filed 2024-08-14 | |||
| 2024-03-31 | 111.70% 10-Q · filed 2024-05-14 | 111.90% 10-Q · filed 2024-05-14 | ||
| 2023-12-31 | 112.00% 10-Q · filed 2024-02-13 | |||
| 2023-09-30 | 57.40% 10-K · filed 2023-12-15 | |||
| 2023-06-30 | 58.10% 10-Q · filed 2024-08-14 | 57.40% 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | 58.10% 10-Q · filed 2024-05-14 | 55.50% 10-Q · filed 2024-05-14 | ||
| 2022-12-31 | 53.50% 10-Q · filed 2024-02-13 | |||
| 2022-09-30 | 53.50% 10-K · filed 2023-12-15 | |||
| 2022-06-30 | 53.50% 10-Q · filed 2023-08-14 | 53.50% 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | 53.50% 10-Q · filed 2023-05-12 | 53.50% 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |